Pharma & Life Sciences
Annual RAS Targeted Drug Development Summit
The Annual RAS Targeted Drug Development Summit is a pivotal event dedicated to advancing RAS-targeted therapies, which have transitioned from being deemed 'undruggable' to becoming a competitive frontier...
The essentials
Event details
- Dates
- 8 September 2026 to 10 September 2026
- Address
- 120 Huntington Avenue, Boston, Massachusetts, USA, 02116
- Organiser
- Hanson Wade Group
- Tickets
- USD 2499 to 5297
- Industry
- Pharma & Life Sciences
Agenda themes
Topics covered
- Medical & Pharma
On stage
Speakers
- Helena Kiefel, Senior Director, Translational Research, Revolution Medicines
- Ivana Sullivan, Clinical Research Medical Director, Amgen Inc
- Thomas Spires, Senior Director Translational Medicine For Adagrasib Development Lead, Bristol Myers Squibb
- Mani Mohindru, President, Chief Executive Officer & Member of the Board, Cardiff Oncology
- Federico Innocenti, Senior Director, Clinical Development - Solid Tumors, BeOne Medicines
- Matthew Farren, Associate Director, Incyte Corporation
- Andrew Stephen, Team Lead, Biochemistry & Biophysics Research Team, NCI, RAS Initiative
- Jonathan Pachter, Chief Scientific Officer, Verastem. inc
On the floor
Sponsors and partners
- Biodesix
- LIDE
- Champions Oncology
- XenoSTART
Logistics
Where to stay
Places to stay near the venue.
Omni Parker House
60 School Street, Boston, 02108
Hotel AKA Boston Common
90 Tremont Street, Boston, 02108
XV Beacon
15 Beacon Street, Boston, 02108
Hyatt Centric Faneuil
54-68 Devonshire Street, Boston, 02109
Churchill at Boston View
Club Quarters Hotel
161 Devonshire Street, Boston, 02110
The Bostonian Boston
The Godfrey Hotel Boston
505 Washington Street, Boston, 02111
Keep planning
Related events
Spot something wrong on this page? Report a correction and we will fix it.